{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:59:01Z","timestamp":1717221541102},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ejphar.2005.12.013","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T09:54:33Z","timestamp":1138355673000},"page":"140-144","source":"Crossref","is-referenced-by-count":14,"title":["The nucleotide derivatives inosine and inosinic acid inhibit intestinal absorption of mizoribine in rats"],"prefix":"10.1016","volume":"531","author":[{"given":"Makoto","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyasu","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.12.013_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1442-200x.2004.01936.x","article-title":"Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis","volume":"46","author":"Abe","year":"2004","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2005.12.013_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00007691-199810000-00018","article-title":"Improving the use of therapeutic drug monitoring","volume":"20","author":"Bates","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2005.12.013_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cccn.2004.03.017","article-title":"Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry","volume":"346","author":"Ceglarek","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2005.12.013_bib4","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/S0041-1345(01)02383-1","article-title":"The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)","volume":"33","author":"Cho","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejphar.2005.12.013_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007691-199312000-00028","article-title":"Use of therapeutic drug monitoring in pharmacoeconomics","volume":"15","author":"Destache","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2005.12.013_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(95)00026-V","article-title":"Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding","volume":"49","author":"Hager","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.013_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0378-4347(00)80663-5","article-title":"Simplified high-performance liquid chromatographic method for determination of mizoribine in human serum","volume":"432","author":"Hosotsubo","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejphar.2005.12.013_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.17.5.770","article-title":"Effects of ribavirin on respiratory syncytial virus in vitro","volume":"17","author":"Hruska","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2005.12.013_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00007890-198302000-00007","article-title":"Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals","volume":"35","author":"Kamata","year":"1983","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2005.12.013_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(85)80012-7","article-title":"Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro","volume":"1","author":"Kawana","year":"1985","journal-title":"Antivir. Res., Suppl."},{"key":"10.1016\/j.ejphar.2005.12.013_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cbf.290070308","article-title":"Dual inhibitory effect of bredinin","volume":"7","author":"Kusumi","year":"1989","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejphar.2005.12.013_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007691-199512000-00004","article-title":"Pharmacokinetics and therapeutic drug monitoring of immunosuppressants","volume":"17","author":"Lindholm","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2005.12.013_bib13","first-page":"38","article-title":"Nephrotic syndrome based on diffuse proliferative lupus nephritis that responded to mizoribine in combination with corticosteroid: a case report","volume":"19","author":"Matsuki","year":"1994","journal-title":"J. Natl. Def. Med. Coll."},{"key":"10.1016\/j.ejphar.2005.12.013_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7164\/antibiotics.27.775","article-title":"Studies on bredinin. I. Isolation, characterization and biological properties","volume":"27","author":"Mizuno","year":"1974","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejphar.2005.12.013_bib15","first-page":"829","article-title":"Absorption, distribution, metabolism and excretion of bredinin in rats","volume":"15","author":"Murase","year":"1978","journal-title":"Oyoyakuri"},{"key":"10.1016\/j.ejphar.2005.12.013_bib16","first-page":"G1314","article-title":"Sodium-dependent nucleoside transport in the human intestinal brush-border membrane","volume":"272","author":"Patil","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.013_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1023\/A:1011945103455","article-title":"Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter","volume":"15","author":"Patil","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.12.013_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007691-199806000-00007","article-title":"Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure","volume":"20","author":"Primmett","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2005.12.013_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","article-title":"A randomized open-label comparative study of conventional therapy versus mizoribine only therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)","volume":"8","author":"Shibasaki","year":"2004","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2005.12.013_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1023\/A:1024296932670","article-title":"The 14-3-3 proteins: gene, gene expression, and function","volume":"28","author":"Takahashi","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2005.12.013_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1328-8067.2002.01535.x","article-title":"Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis","volume":"44","author":"Takei","year":"2002","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2005.12.013_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007691-200404000-00023","article-title":"Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography\u2013mass spectrometry","volume":"26","author":"Taylor","year":"2004","journal-title":"Ther. Drug Monit."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T16:29:47Z","timestamp":1547828987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905013154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0014299905013154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.12.013","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}